Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab

BACKGROUND: Pure red cell aplasia and moderate aplastic anemia are marrow failure states with an immune pathogenesis. Previously, we described short-term improvements in blood counts in two pilot studies treating moderate aplastic anemia (mAA) and pure red cell aplasia (PRCA) patients with daclizuma...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Sloand, Elaine M., Olnes, Matthew J., Weinstein, Barbara, Wu, Colin, Maciejewski, Jaroslaw, Scheinberg, Phillip, Young, Neal S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Ferrata Storti Foundation 2010
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2833067/
https://ncbi.nlm.nih.gov/pubmed/20207845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.013557
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg